Expertise in
13
conditions

Guillaume M. Lefevre

Paris, FR 
Expertise in
13
conditions
Paris, FR 
OverviewLocationsClinical Research

Overview

Guillaume Lefevre practices in Paris, France. Mr. Lefevre is highly rated in 13 conditions, according to our data. His top areas of expertise are Hypereosinophilic Syndrome, Eosinophilic Granulomatosis with Polyangiitis (EGPA, Churg-Strauss Syndrome), Primary Intestinal Lymphangiectasia, Antisynthetase Syndrome, and Kidney Transplant.

His clinical research consists of co-authoring 224 peer reviewed articles and participating in 3 clinical trials. MediFind looks at clinical research from the past 15 years.

Gender
Male

Locations

Paris, 75005, France
Other Locations
CHU Lille
Lille, 59000, France
Suresnes, France
Eu, France
France
Boulogne-billancourt, France
Nantes, France
Gif-sur-yvette, 91191, France
177 Rue De Versailles, Le Chesnay, 78150, France
Rouen, 76000, France
Bondy, France
Thenon, France
Nancy, France

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

3 Clinical Trials

Role of Blood and Tissue Eosinophils in the Fibrogenesis of Systemic Sclerosis
Role of Blood and Tissue Eosinophils in the Fibrogenesis of Systemic Sclerosis
Enrollment Status: Unknown
Publish Date: March 11, 2021
Intervention Type: Diagnostic test
Systematic Search for Primary Immunodeficiency in Adults With Unexplained Recurrent and/or Severe Infections With Encapsulated Bacteria
Systematic Search for Primary Immunodeficiency in Adults With Unexplained Recurrent and/or Severe Infections With Encapsulated Bacteria
Enrollment Status: Terminated
Publish Date: September 18, 2020
Intervention Type: Biological
Study Phase: Not Applicable
A Multi-centre, Open-label Extension, Safety Study to Describe the Long-term Clinical Experience of Mepolizumab in Participants With Hypereosinophilic Syndrome (HES) From Study 200622
A Multi-centre, Open-label Extension, Safety Study to Describe the Long-term Clinical Experience of Mepolizumab in Participants With Hypereosinophilic Syndrome (HES) From Study 200622
Enrollment Status: Completed
Publish Date: June 23, 2020
Intervention Type: Drug
Study Phase: Phase 3
View 2 Less Clinical Trials

221 Total Publications

French laboratories turn-around-time (TAT) for troponin measurement for Emergency Departments: the EN-TRO-PRISE survey
French laboratories turn-around-time (TAT) for troponin measurement for Emergency Departments: the EN-TRO-PRISE survey
Journal: Annales de biologie clinique
Published: June 18, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Lefevre's expertise for a condition
ConditionClose
    View All 12 Advanced Conditions
    View All 66 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile